FDA Inspection 1304480 — Promethean LifeSciences, Inc.

Promethean LifeSciences, Inc. — FEI 3003380161

The FDA completed an inspection of Promethean LifeSciences, Inc. on February 18, 2026 in Pittsburgh, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 18, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Pittsburgh, PA (United States)